EMD-62620

Single-particle
2.82 Å
EMD-62620
3D View Gallery
Deposition: 06/12/2024
Map released: 18/03/2026
Last modified: 18/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62620

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9kwy summary report (pdf.gz) Map-9kwy FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM structure of SARS-CoV-2 RBD in complex with ACE2 and mAb 1C4

EMD-62620

Single-particle
2.82 Å
EMD-62620
3D View Gallery
Deposition: 06/12/2024
Map released: 18/03/2026
Last modified: 18/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mus musculus, Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 RBD in complex with ACE2 and mAb 1C4
Fitted models: 9kwy

Deposition Authors: Sun H, Jiang Y, Li S, Zheng Q , Xia N
Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion.
Sun H, Jiang Y, Lan M, Zhou M, Yi G, Shen J, Deng T, Liu L, Huang Y, Li Y, Su J, Lin Y, Chen Z, Zhou L, Li T, Yu H, Cheng T, Zhang Y, Yuan L, Li S, Gu Y, Zhang P, Xia N, Zheng Q
(2025) PLoS Pathog , 21 , e1013744 - e1013744
PUBMED: 41359663
DOI: doi:10.1371/journal.ppat.1013744
ISSN: 1553-7374
Grant Support: